breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
Marginal read alignment evidence (highest frequency 20 of 449 shown, sorted by frequency from high to low) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
seq id | position | ref | new | freq | score (cons/poly) | reads | annotation | genes | product | ||
* | NZ_CP009273 | 4,036,390 | 0 | A | G | 57.6% | 35.2 / 70.4 | 59 | N206D (AAT→GAT) | srkA | stress response kinase SrkA |
* | NZ_CP009273 | 4,036,353 | 0 | C | T | 46.8% | 36.7 / 24.3 | 62 | F193F (TTC→TTT) | srkA | stress response kinase SrkA |
* | NZ_CP009273 | 2,145,154 | 0 | T | G | 46.0% | 58.7 / 20.9 | 54 | intergenic (+27/+38) | yegJ/pphC | DUF2314 domain‑containing protein/protein‑serine/threonine phosphatase PphC |
* | NZ_CP009273 | 681,493 | 0 | C | A | 45.5% | 6.5 / 10.7 | 22 | S211S (TCG→TCT) | gltJ | glutamate/aspartate ABC transporter permease GltJ |
* | NZ_CP009273 | 684,970 | 0 | A | C | 44.4% | 76.8 / 10.5 | 45 | G456G (GGT→GGG) | lnt | apolipoprotein N‑acyltransferase |
* | NZ_CP009273 | 2,145,111 | 0 | C | A | 43.1% | 88.9 / 29.2 | 54 | A149E (GCA→GAA) | yegJ | DUF2314 domain‑containing protein |
* | NZ_CP009273 | 2,380,341 | 0 | G | A | 42.2% | 65.6 / 56.6 | 64 | intergenic (+31/‑72) | yfbL/yfbM | M28 family metallopeptidase/YfbM family protein |
* | NZ_CP009273 | 3,806,632 | 0 | C | T | 40.2% | 107.8 / 37.9 | 92 | S181L (TCG→TTG) | coaBC | bifunctional phosphopantothenoylcysteine decarboxylase/phosphopantothenate‑‑cysteine ligase CoaBC |
* | NZ_CP009273 | 2,145,105 | 0 | T | A | 40.0% | 86.9 / 18.3 | 54 | L147Q (CTA→CAA) | yegJ | DUF2314 domain‑containing protein |
* | NZ_CP009273 | 2,826,926 | 0 | T | G | 39.8% | 170.9 / 11.7 | 93 | G364G (GGT→GGG) | norV | anaerobic nitric oxide reductase flavorubredoxin |
* | NZ_CP009273 | 2,428,361 | 0 | T | G | 39.7% | 152.4 / 13.2 | 78 | Y252S (TAC→TCC) | truA | tRNA pseudouridine(38‑40) synthase TruA |
* | NZ_CP009273 | 4,612,067 | 0 | A | G | 39.5% | 144.0 / 35.6 | 86 | E161G (GAG→GGG) | yjjJ | type II toxin‑antitoxin system HipA family toxin YjjJ |
* | NZ_CP009273 | 2,997,280 | 0 | T | G | 39.2% | 145.1 / 13.6 | 79 | Y145D (TAT→GAT) | xdhC | xanthine dehydrogenase iron sulfur‑binding subunit XdhC |
* | NZ_CP009273 | 4,570,451 | 0 | C | T | 39.2% | 125.3 / 31.5 | 79 | E277K (GAA→AAA) | hsdS | type I restriction‑modification system specificity subunit |
* | NZ_CP009273 | 4,058,940 | 0 | T | A | 39.2% | 140.6 / 41.6 | 97 | T63S (ACC→TCC) | yihO | MFS transporter |
* | NZ_CP009273 | 2,145,164 | 0 | A | T | 38.9% | 74.9 / 21.1 | 54 | intergenic (+37/+28) | yegJ/pphC | DUF2314 domain‑containing protein/protein‑serine/threonine phosphatase PphC |
* | NZ_CP009273 | 1,429,984 | 0 | G | A | 38.5% | 147.4 / 46.5 | 91 | intergenic (‑108/+33) | uspF/ompN | universal stress protein UspF/porin OmpN |
* | NZ_CP009273 | 4,049,475 | 0 | A | C | 38.4% | 150.8 / 22.7 | 87 | G75G (GGT→GGG) | glnL | nitrogen regulation protein NR(II) |
* | NZ_CP009273 | 1,861,959 | 0 | T | A | 38.2% | 105.6 / 33.9 | 68 | F265L (TTT→TTA) | yeaG | protein kinase YeaG |
* | NZ_CP009273 | 4,277,638 | 0 | G | A | 38.2% | 100.1 / 29.2 | 68 | intergenic (‑339/‑54) | acs/nrfA | acetate‑‑CoA ligase/ammonia‑forming nitrite reductase cytochrome c552 subunit |
Marginal new junction evidence (sorted from low to high skew) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
seq id | position | reads (cov) | reads (cov) | score | skew | freq | annotation | gene | product | ||
* | ? | NZ_CP009273 | = 1203261 | 79 (0.820) | 16 (0.180) | 16/462 | 9.2 | 18.7% | coding (305/630 nt) | BW25113_RS05990 | protein StfP |
? | NZ_CP009273 | = 1205058 | 65 (0.720) | coding (57/540 nt) | BW25113_RS06005 | phage tail protein | |||||
* | ? | NZ_CP009273 | 1203246 = | 79 (0.820) | 14 (0.160) | 14/462 | 10.0 | 16.8% | coding (290/630 nt) | BW25113_RS05990 | protein StfP |
? | NZ_CP009273 | 1205075 = | 65 (0.720) | coding (40/540 nt) | BW25113_RS06005 | phage tail protein | |||||
* | ? | NZ_CP009273 | = 4532507 | 104 (1.080) | 7 (0.080) | 7/476 | 14.0 | 6.6% | intergenic (+57/‑425) | fimE/fimA | type 1 fimbria switch DNA invertase FimE/type 1 fimbrial major subunit FimA |
? | NZ_CP009273 | = 4532803 | 97 (1.050) | intergenic (+353/‑129) | fimE/fimA | type 1 fimbria switch DNA invertase FimE/type 1 fimbrial major subunit FimA | |||||
* | ? | NZ_CP009273 | 4532499 = | 104 (1.080) | 4 (0.040) | 4/476 | 16.1 | 3.9% | intergenic (+49/‑433) | fimE/fimA | type 1 fimbria switch DNA invertase FimE/type 1 fimbrial major subunit FimA |
? | NZ_CP009273 | 4532813 = | 98 (1.060) | intergenic (+363/‑119) | fimE/fimA | type 1 fimbria switch DNA invertase FimE/type 1 fimbrial major subunit FimA |